Atlas Trials

A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Clinical trial NCT05303272 · UNKNOWN

Trial details

NCT number
NCT05303272
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pemphigus Vulgaris
Start date
2021-02-01
Primary completion
2022-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.